InvestSMART

EBOS Group Limited (ASX:EBO)

ALERT: Price-sensitive ASX Announcement for EBO
Current share price for EBO : $16.060 -2.17 (-11.90%)+
Announcement
Release
19 Aug 2026 7:30AM
Price at Release
$18.230
Full Release
download
Summary
EBOS Group Limited reported its financial performance for FY26, showcasing an overall revenue growth of 9.9% and an EBITDA increase of 5.0%. This growth was driven by significant performance in both Healthcare and Animal Care segments, despite facing challenges from fuel and FX costs. The Healthcare segment saw a revenue rise of 8.5%, supported by growth in Community Pharmacy, Hospital Medicines, and Medical Technology. The Animal Care segment also performed strongly, with a revenue increase of 34.6%, attributed to wholesale expansion and new acquisitions. EBOS completed its investment cycle, which included major distribution center renewals, positioning the company for future growth and productivity improvements. The company maintained a leverage ratio within the target range and improved its balance sheet capacity to enable further growth investments.
Key Points
  • EBOS Group achieved a 9.9% revenue growth in FY26.
  • Healthcare revenue increased by 8.5%, driven by multiple sub-segments.
  • Animal Care revenue rose by 34.6%, bolstered by acquisitions and wholesale expansion.
  • Underlying EBITDA grew by 5.0% despite external cost pressures.
  • Completion of distribution center renewals underpins future productivity.
  • Leverage ratio maintained within target range, supporting growth investments.
  • Continued demand across high-value medicines and new product developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.